4
Changes in Ownership
Immix Biopharma, Inc. Filed Acc 0001493152-23-028470
Options or other derivatives
- CEO and Chairman acquired 193,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Rachman Ilya M CEO and Chairman | 2023-08-11 | Grant or award · Stock Options | +193,000 | 193,000 | D | ||
Loading xslF345X05/ownership.xml…